Live
ePaper
Search
Home > India > BRIEF-Avalon Pharma Signs License Agreement For Tirzepatide In Saudi Arabia And MENA Region

BRIEF-Avalon Pharma Signs License Agreement For Tirzepatide In Saudi Arabia And MENA Region

Written By:
Last Updated: October 11, 2026 11:01:46 IST

Oct 11 (Reuters) – MIDDLE EAST PHARMACEUTICAL INDUSTRIES (AVALON PHARMA): * MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY – SIGNS LICENSE AGREEMENT FOR TIRZEPATIDE IN SAUDI ARABIA AND MENA REGION *

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?